Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06006637 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

Study acronym: IPMR ASD
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 14, 2025 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 40 to 80v3 Show 4 more changesShow less
    • Primary and study completion dates: Aug 15, 2024 to Aug 15, 2026
    • Study sites: 1 to 2
    • Collaborators: 1 to 3
    • Study description expanded, about 3 words
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Aug 15, 2023 to Oct 17, 2023
    • Secondary endpoints: details revised at 2 of 2 entries
    • Eligibility criteria shortened, about 3 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University and Mt. Sinai Medical Center with 80 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales.
Trial Details
NCT Number NCT06006637
Lead Sponsor State University of New York - Upstate Medical University
Collaborators: JelikaLite LLC, Mt. Sinai School of Medicine, New York, New York, MetroEHS
Conditions
(from sponsor)		 Autism Spectrum Disorder
Related terms Autism Spectrum Disorder
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov